$720 Million is the total value of Atlas Venture Advisors, Inc.'s 7 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BCYC | Exit | BICYCLE THERAPEUTICS PLCsponsored ads | $0 | – | -307,696 | -100.0% | -1.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-01-27
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SNAP INC | 20 | Q3 2023 | 6.1% |
| ROKU INC | 16 | Q3 2023 | 11.7% |
| LARIMAR THERAPEUTICS INC | 14 | Q3 2023 | 1.4% |
| TRANSLATE BIO INC | 11 | Q2 2021 | 52.9% |
| INTEGRAL AD SCIENCE HLDNG CO | 10 | Q3 2023 | 71.2% |
| BICYCLE THERAPEUTICS PLC | 10 | Q3 2021 | 25.2% |
| VIRIDIAN THERAPEUTICS INC | 10 | Q1 2023 | 2.1% |
| F-STAR THERAPEUTICS INC | 9 | Q4 2022 | 1.3% |
| DRAFTKINGS INC | 8 | Q1 2022 | 82.5% |
| MIRAGEN THERAPEUTICS INC | 8 | Q3 2020 | 5.0% |
View Atlas Venture Advisors, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-13 |
| 13F-HR | 2024-02-02 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-08 |
| 13F-HR | 2023-01-31 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-01-27 |
View Atlas Venture Advisors, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.